EVIO, Inc. engages in the provision of advisory, management, and analytical testing services for the cannabis and hemp industries. The company is headquartered in East Boston, Massachusetts and currently employs 18 full-time employees. The firm provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The firm offers residential and commercial construction services. The firm also offers research and development and consulting services for participants in the cannabis and hemp industries. The firm tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for EVIO. Our analysts highlight strong fundamentals and favorable market sentiment, positioning EVIO for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: EVIO is a Strong Buy candidate.
EVIO stock price ended at $0 on 星期五, after rising NaN%
On the latest trading day Apr 24, 2026, the stock price of EVIO rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 436.1K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 213.7K shares were traded, amounting to a market value of approximately --.